SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-057088
Filing Date
2015-02-23
Accepted
2015-02-23 06:42:02
Documents
6
Period of Report
2015-02-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d878623d8k.htm 8-K 36175
2 EX-2.1 d878623dex21.htm EX-2.1 477383
3 EX-10.1 d878623dex101.htm EX-10.1 337631
4 EX-99.1 d878623dex991.htm EX-99.1 24401
5 GRAPHIC g878623ex99_1img1.jpg GRAPHIC 38595
6 GRAPHIC g878623ex99_1img2.jpg GRAPHIC 9211
  Complete submission text file 0001193125-15-057088.txt   943163
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 15637568
SIC: 2834 Pharmaceutical Preparations